Sirnaomics Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sirnaomics Ltd (2257)
Sirnaomics Ltd stock price live, this page displays HK 2257 stock exchange data. View the 2257 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sirnaomics Ltd real time stock price chart below.
What Is the Sirnaomics Ltd Stock Price Today?
The Sirnaomics Ltd stock price today is 5.54.
What Is the Stock Symbol for Sirnaomics Ltd?
The stock symbol for Sirnaomics Ltd is "2257."
What Stock Exchange Does Sirnaomics Ltd Trade On?
Sirnaomics Ltd is listed and trades on the Hong Kong stock exchange.
Is Sirnaomics Ltd a Good Stock to Buy?
Determining whether Sirnaomics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2257 quote. (ISIN: KYG2050P1028)
What Is the Sirnaomics Ltd Stock Price Today?
The Sirnaomics Ltd stock price today is 5.54.
What Is the Stock Symbol for Sirnaomics Ltd?
The stock symbol for Sirnaomics Ltd is "2257."
What Stock Exchange Does Sirnaomics Ltd Trade On?
Sirnaomics Ltd is listed and trades on the Hong Kong stock exchange.
Is Sirnaomics Ltd a Good Stock to Buy?
Determining whether Sirnaomics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2257 quote. (ISIN: KYG2050P1028)
Hong Kong
Currency in HKD
5.54
-0.31(-5.30%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.50
5.86
52 wk Range
3.10
22.78
2257 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.505.86
52 wk Range
3.1022.78
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2257 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
72.59
Upside
+1,210.22%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price often moves in the opposite direction of the market
- Sirnaomics Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Sirnaomics Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Sirnaomics Ltd PT receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Sirnaomics Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Sirnaomics Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Sirnaomics Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Sirnaomics Ltd PT receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 72.59
(+1,210.22% Upside)
Earnings
Latest Release
Mar 27, 2026
EPS / Forecast
-0.11 / --
Revenue / Forecast
-81K / --
Compare 2257 to Peers and Sector
Metrics to compare | 2257 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2257PeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.3x | −1.4x | −0.5x | |
PEG Ratio | −0.07 | −0.10 | 0.00 | |
Price/Book | −7.8x | 4.0x | 2.6x | |
Price / LTM Sales | - | 3.7x | 3.1x | |
Upside (Analyst Target) | - | 103.3% | 53.0% | |
Fair Value Upside | Unlock | 13.2% | 6.3% | Unlock |
Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs in the People’s Republic of China. The company’s therapeutics products focus on oncology and fibrosis, anticoagulant therapies, cardiometabolic disease, complement-mediated diseases, medical aesthetics, and viral infections. Its lead drug candidates comprising STP705 for the treatment of non-melanoma skin cancer and for focal fat reduction; STP369 to treat head and neck cancer; and STP707 and STP355 to treat solid tumors. The company is also developing STP122G for the treatment of coagulation disorders; STP125G to treat hypertriglyceridemia; and STP144G, STP145G, and STP146G for the treatment of complement diseases. In addition, it is developing STP247G to treat complement diseases; STP152G to treat amyloidosis; STP705 for fat reduction; STP237G and STP251G for the treatment of hypertension in combination with familial hypertriglyceridemia; and STP136G to treat hypertension. The company was incorporated in 2007 and is headquartered in Germantown, Maryland.
Ownership
Ownership Overview
FAQ
What Is the Sirnaomics (2257) Stock Price Today?
The Sirnaomics stock price today is 5.54 HKD.
What Stock Exchange Does Sirnaomics Trade On?
Sirnaomics is listed and trades on the Hong Kong Stock Exchange.
What Is the Stock Symbol for Sirnaomics?
The stock symbol for Sirnaomics is "2257."
What Is the Sirnaomics Market Cap?
As of today, Sirnaomics market cap is 603.30M HKD.
What Is Sirnaomics's Earnings Per Share (TTM)?
The Sirnaomics EPS (TTM) is -0.15.
From a Technical Analysis Perspective, Is 2257 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Sirnaomics Stock Split?
Sirnaomics has split 0 times.
How Many Employees Does Sirnaomics Have?
Sirnaomics has 37 employees.
What is the current trading status of Sirnaomics (2257)?
As of May 23, 2026, Sirnaomics (2257) is trading at a price of 5.54 HKD, with a previous close of 5.85 HKD. The stock has fluctuated within a day range of 5.50 HKD to 5.86 HKD, while its 52-week range spans from 3.10 HKD to 22.78 HKD.
What Is Sirnaomics (2257) Price Target According to Analysts?
The average 12-month price target for Sirnaomics is 72.59 HKD, with a high estimate of 72.5862069 HKD and a low estimate of 72.5862069 HKD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +1,210.22% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.